Medication info
Pitavacare Tablets 2mg (Pitavastatin Calcium)

Pitavacare Tablets 2mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
IlDong Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablet of very light yellow-red color with a score line added.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201103422 · Approved 2011.05.24 · Insurance code 642904230

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
IlDong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • Apo-B protein
  • and triglyceride levels.
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides, and increases HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. By improving blood lipid balance, it contributes to reducing the risk of cardiovascular diseases. Furthermore, its therapeutic effect is enhanced when used in conjunction with dietary management. It is used as an adjunct in the treatment of hyperlipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication is used for the treatment of hypercholesterolemia and is mainly metabolized by the liver. Patients with hypersensitivity to any component of this medication, those with active liver disease, severe hepatic impairment, and pregnant or nursing women should not use this medication. Additionally, this medication contains lactose and should not be administered to patients with genetic metabolic disorders such as galactose intolerance. Patients with impaired renal function or a history of liver dysfunction should use this medication with caution, especially when used in conjunction with fibrates or niacin, as there is a risk of serious muscle disorders such as rhabdomyolysis. During treatment with this medication, symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may occur, and liver function and muscle enzyme levels may increase, making regular monitoring necessary. Rhabdomyolysis, a serious muscle disorder, may rarely occur; therefore, if symptoms such as muscle pain or weakness are present, it is important to consult a physician immediately. This medication is not to be administered to pregnant women, women of childbearing potential, or nursing mothers, and safety and efficacy in pediatric patients have not been established. Caution should also be exercised regarding drug interactions, particularly with cyclosporine, fibrates, niacin, and erythromycin, as these can increase the risk of renal impairment and muscle disorders. During treatment with this medication, dietary modification and exercise therapy should be combined, and regular testing of blood lipids and liver functions should be conducted to monitor therapeutic effects and side effects. Elderly patients should be especially careful, as age-related physiological changes may increase the likelihood of adverse reactions. Finally, this medication should be stored out of reach of children and kept in its original container to maintain its quality.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 80 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • altered taste
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • paresthesia
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • discomfort in the chest
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that prevents light from entering. In addition, it is recommended to store the medication at room temperature, typically between 1°C and 30°C, to maintain its efficacy for as long as possible.

Appearance and packaging

Appearance

Round film-coated tablet of very light yellow-red color with a score line added.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.